Theralase Technologies files unaudited Q2 2026 results; Phase II update
Theralase Technologies Inc. released unaudited interim consolidated financial statements for the six months ended June 30, 2026 and provided updates on its Phase II NMIBC study.
Theralase Technologies Inc. Material DetailsContext by AI AnalystThis is a mid-stage update combining financial filing with maturing Phase II efficacy and r…